(VIANEWS) – Shares of TherapeuticsMD (NASDAQ: TXMD) fell 5.55% to $0.32 at 09:43 EST on Wednesday, after two sequential sessions in a row of losses. NASDAQ is sliding 2.6% to $14,506.90, following the last session’s downward trend. This seems, at the moment, an all-around down trend trading session today.
TherapeuticsMD’s last close was $0.34, 87.81% below its 52-week high of $2.75.
Today’s last reported volume for TherapeuticsMD is 350319 which is 94.22% below its average volume of 6065130.
TherapeuticsMD’s sales growth is 33.7% for the current quarter and 29.3% for the next. The company’s growth estimates for the current quarter and the next is 16.7% and 40%, respectively.
Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.
TherapeuticsMD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.62%, a negative 0.88%, and a positive 5.83%, respectively.
TherapeuticsMD’s highest amplitude of average volatility was 3.85% (last week), 4.35% (last month), and 5.83% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
TherapeuticsMD’s stock is considered to be oversold (<=20).
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $0.32 at 09:43 EST, way below its 52-week low of $0.37.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s value is way under its 50-day moving average of $0.66 and way below its 200-day moving average of $1.00.
More news about TherapeuticsMD (TXMD).